Nutriceutical and pharmaceutical formulations for treating
neurodegenerative disorders such as Alzheimer's disease are provided.
Nutriceutical formulations include two or more of folate, vitamin E, and
acetyl-L-carnitine (ALCAR). Pharmaceutical formulations include two or
more of 3-deaza-adenosine (DZA), N-acetyl-L-cysteine (NAC), and
S-adenosylmethionine (SAM).
